Correction to: Diabetology International (2018) 9:1–45 10.1007/s13340-018-0345-3
In the published guideline, the following financial information that the authors submitted to the editorial office was inadvertently omitted from the manuscript:
Conflict of interest
Author MH received honoraria for lectures for Astellas Pharma Inc., Taisho Toyama Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Boehringer Ingelheim Japan, Inc., Taisho Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., MSD K.K., Novartis Pharma K.K., Novo Nordisk Pharma Ltd., and Sanofi K.K. Author MH received scholarship grants from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Co., Ltd., Taisho Toyama Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., Elli-Lilly Japan K.K., Boehringer Ingelheim Japan, Inc., Kyowa Hakko Kirin Co. Ltd., Ono Pharmaceutical Co., Ltd., Kowa Pharmaceutical Co., Ltd., Sanofi K.K., Shionogi & Co., Ltd., Johnson & Johnson K.K., Otsuka Pharmaceutical Co., Ltd., and Kissei Pharmaceutical Co., Ltd. Author MN received honoraria for lectures for MSD K.K. Author MN received scholarship grants from Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Co., Ltd., MSD K.K., Novo Nordisk Pharma Ltd., Takeda Pharmaceutical Co., Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Co., Ltd., Boehringer Ingelheim International GmbH, and Sumitomo Dainippon Pharma Co., Ltd. Author HN received honoraria for lectures for Elli Lilly Japan K.K. Author DY received honoraria for lectures for Novo Nordisk Pharma Ltd., Boehringer Ingelheim Japan, Inc. Author DY received research grants from Terumo Corporation. Author DY received scholarship grants from Taisho Toyama Pharmaceutical Co., Ltd., MSD K.K., Ono Pharmaceutical Co. Ltd., Novo Nordisk Pharma Ltd., Arklay Inc., and Takeda Pharmaceutical Co. Ltd. Author EA received honoraria for lectures for MSD K.K., Ono Pharmaceutical Co., Ltd., Sanofi K.K., Novo Nordisk Inc. Author EA received scholarship grants from Astellas Pharma Inc., Novo Nordisk Inc., Pfizer Japan Inc, Ono Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., and Sanofi K.K. Author HO, author YF, author AG, and author TK declare that they have no conflict of interest.
Ethics policy
The article does not contain any studies with human or animal subjects performed by any of the authors.